BioCentury
ARTICLE | Company News

MacroGenics, J&J deal

September 21, 2015 7:00 AM UTC

MacroGenics received a $10 million milestone payment from Johnson & Johnson’s Janssen Biotech Inc. unit under a 2014 deal granting the unit exclusive, worldwide rights to MGD011 ( JNJ-64052781). The ...